Metagenomi, Inc. Common Stock
Metagenomi, Inc. Common Stock (MGX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mgx · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$22.00
Consensus
$14.50
+1024.0% upside
Low
$7.00
Median: $14.5 · Last Close: $1.29
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.28 | ↓ 0.85% |
1-day model range: $1.27–$1.28. Peak: $1.28 (-0.85%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MGX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-05-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-05-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | Wells Fargo | Maintains | Overweight→Overweight |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Metagenomi, Inc. Common Stock (MGX) stock. Of the recent 21 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover MGX.
Analyst Recommendation Trends
MGX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$12M
↓ 39.3% YoY
Revenue Next Year
$13M
↑ 3.1% YoY
EPS This Year
$-2.12
EPS Next Year
$-1.57
↓ 26.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast MGX EPS of $-2.12 for the current fiscal year, based on estimates from 2 analysts. The MGX revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MGX stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MGX price target is $14.50 (+1024.0% upside), with an analyst consensus of Buy.
The MGX short-term stock prediction for tomorrow is $1.28 (-0.85%). The MGX stock price prediction for 2027 estimates an average of $1. The MGX stock prediction for 2030 projects a range of $0–$0.
Metagenomi, Inc. Common Stock trades on NASDAQ under the ticker MGX. The MGX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
MGX forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month MGX price target is $14.50, with a high forecast of $22.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +1024.0% potential upside from the current price of $1.29.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.